Skip to main content
In stock | Immunotherapy (Investigational)

Utomilumab

Oncology Type Solid Tumour
Drug Class / Mechanism Costimulatory / Bispecific Agent
No Image
Description

Utomilumab is classified as a Costimulatory / Bispecific Agent, sourced for use within our Immunotherapy (Investigational) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Immunotherapy (Investigational)
Oncology Type Solid Tumour

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3